Gain Therapeutics, Inc.
USD1.84
+0.21 (+12.88%)
CEO
Gene Mack
IPO Date
2021-03-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.64
Prev. Close
$1.63
Day Low
$1.63
Day High
$1.85
52W Low
$1.41
52W High
$4.34
Market Cap
$0.08B
Volume
0.68M
| 25,000 |
| $1.68 |
| 17 Jul 2026 | Islam Khalid | director | A-Award | Acquired | 25,000 | $1.68 |
| 17 Jul 2026 | Melincoff Gwen A | director | A-Award | Acquired | 25,000 | $1.68 |
| 17 Jul 2026 | Riley Jeffrey Scott | director | A-Award | Acquired | 25,000 | $1.68 |
| 17 Jul 2026 | HASLER HANS PETER | director | A-Award | Acquired | 25,000 | $1.68 |
| 26 Mar 2026 | Mack Gene | director, officer: CEO, President | A-Award | Acquired | 200,000 | $1.86 |
| 26 Mar 2026 | Fuggetta Gianluca | See Remark | A-Award | Acquired | 50,000 | $1.86 |
| 25 Jun 2025 | Islam Khalid | director | A-Award | Acquired | 15,000 | $1.79 |
| 25 Jun 2025 | Nicaise Claude | director | A-Award | Acquired | 15,000 | $1.79 |